Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902)
Clinical Trial Grant
Awarded By
Grid Therapeutics LLC
Start Date
April 22, 2020
End Date
February 28, 2026
Awarded By
Grid Therapeutics LLC
Start Date
April 22, 2020
End Date
February 28, 2026